- Service Name
HOLMES Nucleic Acid Detection Platform
- Industry
Healthcare, Diagnostics, Molecular Diagnostics, CRISPR Technology
- Main Value Proposition
The HOLMES platform provides a rapid, cost-effective, and highly efficient solution for nucleic acid detection, making it suitable for a wide range of diagnostic applications.
- Description
The HOLMES platform is a rapid nucleic acid detection technology based on the CRISPR-Cas12 protein, offering high sensitivity and specificity. It is designed for various applications including pathogen detection, genetic disease screening, and precision medicine.
- Key Features
Ultra-fast results compared to traditional testing; High specificity to distinguish SNP sites; Low cost compared to traditional testing; High sensitivity with a limit of detection down to single copy numbers
- Use Cases
The primary scenarios where the service is most valuable include pathogen detection, SNP testing, disease screening, antibiotic resistance testing, animal disease detection, bacterial testing, and food safety.
- Competitive advantages
Faster testing times than traditional methods; Higher specificity and sensitivity; Lower operational costs compared to conventional diagnostic techniques
- Strengths
The platform's strengths lie in its rapid response time, cost-effectiveness, and high accuracy, making it a versatile tool for various diagnostic needs.
- Positioning
The service positions itself as a cutting-edge solution in the molecular diagnostics market, focusing on speed, cost-efficiency, and accuracy.
- Audience
The target users include healthcare professionals, diagnostic laboratories, researchers in molecular biology, and companies involved in precision medicine.
- CTA
Apply for a trial kit
- Tags
CRISPR
Nucleic Acid Testing
Molecular Diagnostics
Pathogen Detection
- Tagline
one-HOur Low-cost Multipurpose highly Efficient System
- Tone of Voice
Innovative, authoritative, professional
- Differentiation
The HOLMES technology leverages the unique advantages of CRISPR-Cas12, which has been recognized as a next-generation molecular diagnostic technology by 'Science' magazine.
- Brand Positioning
ToloBio is positioned as an innovative leader in the CRISPR diagnostic industry, emphasizing collaboration and advancement in molecular diagnostics.
- Founded
2014-01-01